Filing Manager
Deep Track Capital, LP
Reporting Manager
Deep Track Capital, LP
Symbol
BCYC
Shares outstanding
49,630,939 shares
Disclosed Ownership
3,330,236 shares
Ownership
6.7%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 08:41:11 UTC
Date of event
31 Dec 2024
Next filing
15 May 2025

Sponsored

Quoteable Key Fact

"Deep Track Capital, LP disclosed 6.7% ownership in Bicycle Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC) on 31 Dec 2024."

Quick Takeaways

  • Deep Track Capital, LP filed SCHEDULE 13G/A for Bicycle Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value (pound)0.01 per share (BCYC).
  • Disclosed ownership: 6.7%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Feb 2025, 08:41.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deep Track Capital, LP 6.7% 3,330,236 0 3,330,236 /s/ David Kroin David Kroin, Managing Member of the General Partner of the Investment Adviser
Deep Track Biotechnology Master Fund, Ltd. 6.7% 3,330,236 0 3,330,236 /s/ David Kroin David Kroin, Director
David Kroin 6.7% 3,330,236 0 3,330,236 /s/ David Kroin David Kroin